Investing in tomorrow.

We fuel early-stage companies pioneering technologies across advanced computing, biomedical engineering, cybersecurity, and infrastructure.
Our team of investors includes PhD scientists, combat veterans, practicing physicians, and successful entrepreneurs — we provide unique insight and strategic value from a wide breadth of experiences and backgrounds.

We are bold counsel to innovators creating a brighter, safer, and healthier future — and we seek out companies who align with our values.
We invest in the future of
WE ARE

We are specific about our investments and deliberate in our partnerships. We only invest when we know the product, the market, and how to help founders grow their business.

Our discipline begins with a critical question: "Why is J2 Ventures the right partner?" We only proceed when we find an answer that ensures mutual success.

Our strong relationships with founders are a point of pride. Acting as an integral part of their team, we are committed to finding solutions, leveraging our expertise, and providing resources to address any challenge.

Our Philosophy

They are true partners who act as integrated members of our team and force multipliers.

—Jason Park, PhD, CEO of Empress Therapeutics
Perspectives
that drive value.

Our team has a unique combination of expertise across government, finance, operations, science, health, and technology.

Our People
Latest from J2 Ventures
Latest from J2 Ventures
Latest from J2 Ventures
Latest from J2 Ventures
Latest from J2 Ventures
Latest from J2 Ventures
Latest from J2 Ventures
Latest from J2 Ventures
Latest from J2 Ventures
Latest from J2 Ventures
Latest from J2 Ventures
Latest from J2 Ventures
Latest from J2 Ventures
Latest from J2 Ventures
Latest from J2 Ventures
Latest from J2 Ventures
Latest from J2 Ventures
Latest from J2 Ventures
Latest from J2 Ventures
Latest from J2 Ventures
Latest from J2 Ventures

PITCHBOOK

As Hegseth cozies up to Silicon Valley, VCs’ defense tech investing is getting frothy

Read Article

CNBC

Musubi, AI content moderation startup, raises $5 million in seed funding

Read Article

MORNINGSTAR

Micron Biomedical Extends Series A Financing to 33+ Million to Accelerate Commercialization of Needle-Free...

Read Article
J2 Insights
How America Lost its Global Connectivity Lead and Why the Future Depends on Getting it Back
Read Article